CJC-1295 (7.5mg) with Ipamorelin (15mg) is a synergistic peptide combination designed for research focused on growth hormone modulation, cellular repair, and metabolic enhancement. CJC-1295 is a potent GHRH analogue known for its extended half-life, allowing sustained GH release in experimental models. Ipamorelin, a highly selective GH secretagogue, complements CJC-1295 by stimulating ghrelin receptors without affecting other hormonal pathways.
Together, this combination is widely utilized in preclinical studies examining growth hormone physiology, tissue regeneration, metabolic shifts, and anti-inflammatory cellular responses.
The product is supplied as a lyophilized dual-strength peptide blend, ensuring high purity and stability for controlled laboratory use. When reconstituted, the formula maintains structural integrity for consistent experimental outcomes.
Research Applications
This combination is commonly studied for its potential role in:
Endogenous GH and IGF-1 pathway stimulation
Muscle recovery and protein synthesis research
Cellular repair and regenerative modeling
Metabolic rate enhancement and lipolysis studies
Sleep cycle and circadian rhythm research
Anti-inflammatory and tissue-support mechanisms
Researchers value this pairing for its balanced activity—CJC-1295 provides prolonged GH stimulation, while Ipamorelin offers clean, selective receptor activation.
Product Specifications
Name: CJC-1295 + Ipamorelin
Strengths:
CJC-1295: 7.5mg
Ipamorelin: 15mg
Form: Lyophilized sterile peptide blend
Purity: ≥ 98% (HPLC verified)
Storage:
Lyophilized: –20°C, protected from light
Reconstituted: refrigerate under sterile conditions
Intended Use: Laboratory and research use only
Dynasty Clinic Note
At Dynasty Clinic, peptide-related information such as CJC-1295/Ipamorelin is provided strictly for scientific and educational purposes. The clinic supports advanced regenerative science while ensuring all peptide descriptions remain compliant, safe, and non-medical.